Massmedica S.A. (WSE:MSM)

Market Cap	9.61M
Revenue (ttm)	32.61M
Net Income (ttm)	625.88K
Shares Out	2.41M
EPS (ttm)	0.26
PE Ratio	15.36
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2
Average Volume	2,213
Open	3.980
Previous Close	3.980
Day's Range	3.980 - 3.980
52-Week Range	3.200 - 9.000
Beta	0.48
RSI	42.53
Earnings Date	Aug 11, 2025

About Massmedica

Massmedica S.A. engages in the distribution of implants and other medical materials used in the treatment of musculoskeletal system diseases and regenerative medicines in Poland. It offers products in the field of reconstructive, regenerative, anti-aging, and aesthetic medicine. The company’s products include dietary supplements, skin care cosmetics, sun protection creams, tools for home treatments, and intra-articular injections for regeneration of the knee joints. It also provides reconstructive products, such as hip endoprostheses, 3D endopo...

• Industry: Medical, Dental, and Hospital Equipment and Supplies
• Founded: 2011
• Employees: 17
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: MSM

Financial Performance

In 2024, Massmedica's revenue was 32.61 million, an increase of 23.72% compared to the previous year's 26.36 million. Earnings were 625,876, an increase of 100.78%.